Background: PBC for RFT recurrent TN. Methods: A retrospective analysis of 174 patients with recurrent TN who had previously undergone RFT and required secondary intervention (RFT group, n = 99 or PBC group, n = 75) between January 1, 2020 and April 30, 2024. The Numeric Rating Scale score, recurrence-free survival rate, Barrow Neurological Institute facial numbness (BNI-N) score, and other complications were assessed before surgery and all postoperative follow-up time points. Results: < 0.001). No severe complications were observed in either of the 2 groups. Conclusions: Both repeat RFT and PBC can effectively provide short-term pain relief for patients with RFT recurrent TN. Compared to repeat RFT, PBC represents a preferable therapeutic option for long-term pain relief efficacy and lower recurrence rates at 1-year follow-up.
Meng et al. (Thu,) studied this question.